Skip to main content
November 06

November 06, 2018
Frankfurt, Germany

Roadshow Frankfurt

November 07

November 07, 2018
Geneva, Switzerland

Roadshow Geneva

Arsenic Trioxide Injection is the newest addition to the company’s oncology portfolio.

Fresenius Kabi HYDROmorphone Hydrochloride injection is a new offering for the company, expanding its analgesia and anesthesia portfolio. It is available in six single-dose vial presentations.

Palonosetron Hydrochloride Injection is now available in the U.S. and is the newest product in the company’s Simplist™ prefilled syringe portfolio.  It is an antiemetic used to manage chemotherapy-induced nausea and vomiting. Fresenius Kabi is the first company to offer U.S. customers Palonosetron Hydrochloride in a ready-to-administer syringe.

Fresenius Kabi has launched Heparin Sodium injection in ready-to-administer non-DEHP freeflex® bags, expanding the company’s critical care portfolio. Fresenius Kabi offers a comprehensive portfolio of Heparin Sodium in the U.S. with multiple vial presentations, a pre-filled syringe and bag presentations.

November 01

November 01, 2018
Boston, USA

Roadshow Boston

November 05

November 05, 2018
Paris, France

Roadshow Paris

October 31

October 31, 2018
London, UK

Roadshow London

October 31

October 31, 2018
New York, USA

Roadshow New York

Subscribe to